BUSINESS
Rakuten Joins Hands with LOTTE Biologics to Boost Production for Photoimmunotherapy
Rakuten Medical said on January 13 that it has signed a manufacturing agreement with South Korea’s LOTTE Biologics to strengthen its production capacity for biologic drugs used in its photoimmunotherapy programs, as development advances and commercialization plans take shape. Under…
To read the full story
Related Article
- Lotte Invests in Rakuten Medical via Biopharma CVC
April 3, 2026
- Lotte to Step Up CVC Investments to Drive CDMO Synergies
March 10, 2026
BUSINESS
- Takeda CEO Says Orzeyful Could Redefine NT1 Standard of Care
July 31, 2026
- Pfizer Seeks Pediatric Expansion for Hympavzi in Japan
July 31, 2026
- Nippon Shinyaku Exercises Option for AB2 Bio’s Tadekinig Alfa in US
July 31, 2026
- Alfresa Takes Stake in Ember to Bolster Pharma Cold Chain in Japan
July 31, 2026
- Sanwa Kagaku Says Kumamoto Plant Remains Shut, Drug Supplies Stable
July 31, 2026
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…





